Jinxin Fertility Group Limited (abbreviated as JXR) disclosed a Next Day Disclosure Return on 10 April 2026, detailing the latest movement in its share capital.

The company bought back 3.20 million ordinary shares on the Hong Kong Stock Exchange on 10 April 2026. The repurchases were executed at prices ranging from HKD 2.44 to HKD 2.47 per share, with a total cash outlay of HKD 7.89 million. All of the shares are intended for cancellation.

Including this transaction, JXR now has 9.51 million repurchased shares pending cancellation. These buybacks were carried out in four tranches between 27 March and 10 April 2026 at a volume-weighted average cost of HKD 2.33–2.47 per share.

As of the close of 10 April 2026, the company’s issued share capital remained unchanged at 2,705.04 million shares because the repurchased shares had not yet been cancelled. Under the general mandate approved on 26 June 2025, JXR is authorised to repurchase up to 274.47 million shares; 49.17 million shares—equivalent to 1.79 % of the share base at the mandate date—have been repurchased so far.

A statutory 30-day moratorium on new share issues or treasury share disposals applies until 10 May 2026 following the latest buyback, in line with Hong Kong listing rules.